Search results
Results from the WOW.Com Content Network
The Asthma Life Impact Scale (ALIS) measure is a disease-specific patient reported outcome questionnaire which assesses the impact that asthma has on a patient’s quality of life. [ 1 ] The questionnaire has 22 items, [ 1 ] which goes beyond earlier focus on the symptoms, functioning and environmental triggers of asthma and includes emotional ...
Similarly, critical care scientists are involved in many aspects of patient critical care care that respiratory therapists might, including the management and application of invasive ventilation technologies and other respiratory adjuncts as ell as point-of-care blood testing (including interpreting the results for other clinicians), but are ...
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
Speech–language pathology (a.k.a. speech and language pathology or logopedics) is a healthcare and academic discipline concerning the evaluation, treatment, and prevention of communication disorders, including expressive and mixed receptive-expressive language disorders, voice disorders, speech sound disorders, speech disfluency, pragmatic language impairments, and social communication ...
The Academy is dedicated to the advancement of the knowledge and practice of allergy, asthma and immunology for optimal patient care. Most members of the AAAAI are board-certified allergist/immunologists. [2] A select group of the membership are elected as Fellows and carry the title FAAAAI. [3]
The proposed mechanism is that while LABAs relieve asthma symptoms, they can also promote bronchial inflammation and sensitivity without warning. [23] On February 18, 2011, the FDA issued a safety alert for long-acting β agonists. [24]
The Asthma and Allergy Foundation of America (AAFA) is the leading patient organization for people with asthma and allergies and the oldest asthma and allergy patient group in the world. AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education ...